Standard

Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy. / Pashkina, Ekaterina; Bykova, Maria; Berishvili, Maria и др.

в: Cells, Том 14, № 2, 61, 07.01.2025.

Результаты исследований: Научные публикации в периодических изданиях › статья › Рецензирование

Harvard

Pashkina, E, Bykova, M, Berishvili, M, Lazarev, Y & Kozlov, V 2025, 'Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy', Cells, Том. 14, № 2, 61. https://doi.org/10.3390/cells14020061

APA

Pashkina, E., Bykova, M., Berishvili, M., Lazarev, Y., & Kozlov, V. (2025). Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy. Cells, 14(2), [61]. https://doi.org/10.3390/cells14020061

Vancouver

Pashkina E, Bykova M, Berishvili M, Lazarev Y, Kozlov V. Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy. Cells. 2025 янв. 7;14(2):61. doi: 10.3390/cells14020061

Author

Pashkina, Ekaterina ; Bykova, Maria ; Berishvili, Maria и др. / Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy. в: Cells. 2025 ; Том 14, № 2.

BibTeX

@article{5cf31e0f1d544ee88bd59b60028780cf,
title = "Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy",
abstract = "In recent years, hyaluronic acid (HA) has attracted increasing attention as a promising biomaterial for the development of drug delivery systems. Due to its unique properties, such as high biocompatibility, low toxicity, and modifiability, HA is becoming a basis for the creation of targeted drug delivery systems, especially in the field of oncology. Receptors for HA overexpressed in subpopulations of cancer cells, and one of them, CD44, is recognized as a molecular marker for cancer stem cells. This review examines the role of HA and its receptors in health and tumors and analyzes existing HA-based delivery systems and their use in various types of cancer. The development of new HA-based drug delivery systems will bring new opportunities and challenges to anti-cancer therapy.",
keywords = "cancer therapy, drug delivery system, extracellular matrix, hyaluronic acid, nanoparticle, supramolecular system",
author = "Ekaterina Pashkina and Maria Bykova and Maria Berishvili and Yaroslav Lazarev and Vladimir Kozlov",
note = "This study was funded by the Russian Science Foundation according to research project No. 23-25-00375.",
year = "2025",
month = jan,
day = "7",
doi = "10.3390/cells14020061",
language = "English",
volume = "14",
journal = "Cells",
issn = "2073-4409",
publisher = "MDPI AG",
number = "2",

}

RIS

TY - JOUR

T1 - Hyaluronic Acid-Based Drug Delivery Systems for Cancer Therapy

AU - Pashkina, Ekaterina

AU - Bykova, Maria

AU - Berishvili, Maria

AU - Lazarev, Yaroslav

AU - Kozlov, Vladimir

N1 - This study was funded by the Russian Science Foundation according to research project No. 23-25-00375.

PY - 2025/1/7

Y1 - 2025/1/7

N2 - In recent years, hyaluronic acid (HA) has attracted increasing attention as a promising biomaterial for the development of drug delivery systems. Due to its unique properties, such as high biocompatibility, low toxicity, and modifiability, HA is becoming a basis for the creation of targeted drug delivery systems, especially in the field of oncology. Receptors for HA overexpressed in subpopulations of cancer cells, and one of them, CD44, is recognized as a molecular marker for cancer stem cells. This review examines the role of HA and its receptors in health and tumors and analyzes existing HA-based delivery systems and their use in various types of cancer. The development of new HA-based drug delivery systems will bring new opportunities and challenges to anti-cancer therapy.

AB - In recent years, hyaluronic acid (HA) has attracted increasing attention as a promising biomaterial for the development of drug delivery systems. Due to its unique properties, such as high biocompatibility, low toxicity, and modifiability, HA is becoming a basis for the creation of targeted drug delivery systems, especially in the field of oncology. Receptors for HA overexpressed in subpopulations of cancer cells, and one of them, CD44, is recognized as a molecular marker for cancer stem cells. This review examines the role of HA and its receptors in health and tumors and analyzes existing HA-based delivery systems and their use in various types of cancer. The development of new HA-based drug delivery systems will bring new opportunities and challenges to anti-cancer therapy.

KW - cancer therapy

KW - drug delivery system

KW - extracellular matrix

KW - hyaluronic acid

KW - nanoparticle

KW - supramolecular system

UR - https://www.mendeley.com/catalogue/bd04ed8e-d6ea-396b-a85a-c43c806ea97e/

UR - https://www.scopus.com/record/display.uri?eid=2-s2.0-85215966185&origin=inward&txGid=e32b8bbc40f8b51dd55ed2e3d223a102

U2 - 10.3390/cells14020061

DO - 10.3390/cells14020061

M3 - Article

C2 - 39851489

VL - 14

JO - Cells

JF - Cells

SN - 2073-4409

IS - 2

M1 - 61

ER -

ID: 63690260